Cargando…

CC16 as an Inflammatory Biomarker in Induced Sputum Reflects Chronic Obstructive Pulmonary Disease (COPD) Severity

PURPOSE: The progression of an abnormal inflammatory response plays a crucial role in the lung function decline of chronic obstructive pulmonary disease (COPD) patients. Compared to serum biomarkers, inflammatory biomarkers in induced sputum would be a more reliable reflection of inflammatory proces...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Mengjie, Xu, Kan, He, Yuting, Jin, Jianjun, Mao, Ruolin, Gao, Lei, Zhang, Yi, Wang, Gang, Gao, Peng, Xie, Min, Liu, Chunfang, Chen, Zhihong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2023
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10150740/ https://www.ncbi.nlm.nih.gov/pubmed/37139166 http://dx.doi.org/10.2147/COPD.S400999

Ejemplares similares

Induced sputum metabolomic profiles and oxidative stress are associated with chronic obstructive pulmonary disease (COPD) severity: potential use for predictive, preventive, and personalized medicine
por: Zhu, Tao, et al.
Publicado: (2020)

Sputum cell count: biomarkers in the differentiation of asthma, COPD and asthma–COPD overlap
por: Gao, Jie, et al.
Publicado: (2017)

CC16 augmentation reduces exaggerated COPD-like disease in Cc16-deficient mice
por: Rojas-Quintero, Joselyn, et al.
Publicado: (2023)

Characterization of sputum biomarkers for asthma–COPD overlap syndrome
por: Gao, Jing, et al.
Publicado: (2016)

Stable Chronic Obstructive Pulmonary Disease (COPD) Management Under a Tiered Medical System in China
por: Mao, Ruolin, et al.
Publicado: (2022)

Microparticles in sputum of COPD patients: a potential biomarker of the disease?
por: Lacedonia, Donato, et al.
Publicado: (2016)

Characterization of sputum biomarkers for asthma–COPD overlap syndrome [Erratum]
Publicado: (2017)

Influence of Cell Quality on Inflammatory Biomarkers in COPD Sputum Supernatant
por: Pedersen, Frauke, et al.
Publicado: (2021)

Validation of Sputum Biomarker Immunoassays and Cytokine Expression Profiles in COPD
por: Mulvanny, Alex, et al.
Publicado: (2022)

Relationships of serum CC16 levels with smoking status and lung function in COPD
por: Gribben, Kelli C., et al.
Publicado: (2022)

Sputum neutrophils as a biomarker in COPD: findings from the ECLIPSE study
por: Singh, Dave, et al.
Publicado: (2010)

Predictive Value of Serum Markers SFRP1 and CC16 in Acute Exacerbation of Chronic Obstructive Pulmonary Disease
por: He, Yewei, et al.
Publicado: (2022)

CC16: A Biomarker of Pollutant Exposure and Future Lung Disease?
por: Laing, Ingrid A.
Publicado: (2019)

Sputum microbiology predicts health status in COPD
por: Braeken, Dionne CW, et al.
Publicado: (2016)

Reduced Serum Concentration of CC16 Is Associated with Severity of Chronic Obstructive Pulmonary Disease and Contributes to the Diagnosis and Assessment of the Disease
por: Rong, Biaoxue, et al.
Publicado: (2020)

Sputum myeloperoxidase in chronic obstructive pulmonary disease
por: Zhu, Alling, et al.
Publicado: (2014)

Correlation between fractional exhaled nitric oxide and sputum eosinophilia in exacerbations of COPD
por: Gao, Jie, et al.
Publicado: (2017)

Blood and sputum eosinophils in COPD; relationship with bacterial load
por: Kolsum, Umme, et al.
Publicado: (2017)

Sputum Vitamin D Binding Protein (VDBP) GC1S/1S Genotype Predicts Airway Obstruction: A Prospective Study in Smokers with COPD
por: Gao, Jing, et al.
Publicado: (2020)

Recombinant club cell protein 16 (CC16) ameliorates cigarette smoke-induced lung inflammation in a murine disease model of COPD
por: Pang, Min, et al.
Publicado: (2018)

The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils
por: Ditz, Benedikt, et al.
Publicado: (2021)

Repression of CC16 by Cigarette Smoke (CS) Exposure
por: Zhu, Lingxiang, et al.
Publicado: (2015)

Clinical and pulmonary function changes in cough variant asthma with small airway disease
por: Yuan, Honglei, et al.
Publicado: (2019)

Repeatability of and Relationship between Potential COPD Biomarkers in Bronchoalveolar Lavage, Bronchial Biopsies, Serum, and Induced Sputum
por: Röpcke, Stefan, et al.
Publicado: (2012)

Responsivity and Reproducibility of Sputum Inflammatory Biomarkers During COPD Exacerbation and Stable Phases – A Pilot Study
por: Ditz, B, et al.
Publicado: (2021)

Sputum microbiota and inflammation at stable state and during exacerbations in a cohort of chronic obstructive pulmonary disease (COPD) patients
por: Tangedal, Solveig, et al.
Publicado: (2019)

Dyspnea assessment and adverse events during sputum induction in COPD
por: Makris, Demosthenes, et al.
Publicado: (2006)

Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients
por: Harju, Terttu H, et al.
Publicado: (2007)

Anxiety and depression in COPD patients and correlation with sputum and BAL cytology
por: Tetikkurt, Cuneyt, et al.
Publicado: (2011)

Sputum Bacterial and Fungal Dynamics during Exacerbations of Severe COPD
por: Su, Jin, et al.
Publicado: (2015)

Bacterial flora in the sputum and comorbidity in patients with acute exacerbations of COPD
por: Boixeda, Ramon, et al.
Publicado: (2015)

Protein networks in induced sputum from smokers and COPD patients
por: Baraniuk, James N, et al.
Publicado: (2015)

Reduced sputum expression of interferon-stimulated genes in severe COPD
por: Hilzendeger, Clarissa, et al.
Publicado: (2016)

Validation of the breathlessness, cough and sputum scale to predict COPD exacerbation
por: DeVries, Rebecca, et al.
Publicado: (2016)

Short term dynamics of the sputum microbiome among COPD patients
por: Sinha, Rohita, et al.
Publicado: (2018)

Sputum Streptococcus pneumoniae is reduced in COPD following treatment with benralizumab
por: George, Leena, et al.
Publicado: (2019)

Sputum microbiome profiling in COPD: beyond singular pathogen detection
por: Ditz, Benedikt, et al.
Publicado: (2020)

Genetic regulators of sputum mucin concentration and their associations with COPD phenotypes
por: Van Buren, Eric, et al.
Publicado: (2023)

Activity of sputum p38 MAPK is correlated with airway inflammation and reduced FEV(1) in COPD patients
por: Huang, Cuiping, et al.
Publicado: (2013)

CC16: A Treatable Trait in Asthma?
por: Bloom, Chloe I., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2jvjhn2v89glaqb11ekkmd3pge